Medium term results of HEMA intraocular lenses (Hydroview).
A group of 232 eyes that received a HEMA IOL (Hydroview, Storz Inc.) was followed over a period of six months. Mean visual acuity increased from 0.41 preoperatively to 0.79 post-operatively. During the follow-up period, the visual acuity remained stable in 175 eyes and decreased in 57 eyes, mainly due to progression of ARMD and posterior capsule opacification (PCO). Nine eyes required YAG-laser capsulotomy. Cell migration on the anterior surface of the Hydroview IOL was observed in 100% of the cases after a period of 3 months.
Goarnisson
S
S
Department of Ophthalology, A.Z.V.U.B., University of Brussels.
Hennekes
R
R
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002387:Cataract Extraction; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate; D007910:Lenses, Intraocular; D008297:Male; D008875:Middle Aged; D013508:Ophthalmologic Surgical Procedures; D016896:Treatment Outcome; D014792:Visual Acuity
D020136:Hydrogel, Polyethylene Glycol Dimethacrylate